AstraZeneca vs AT&T: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: AstraZeneca and AT&T side by side

1. 1885AT&T

   AT&T Founded as the Bell System Long-Distance Arm

   American Telephone and Telegraph was incorporated in 1885 to build and operate long-distance telephone lines for the Bell system.

2. 1913AstraZeneca

   Astra AB Founded in Södertälje, Sweden

   400 doctors and apothecaries establish Astra AB to manufacture pharmaceuticals for the Swedish market, creating the foundation for what would become one of Europe's largest drug companies.

3. 1913AT&T

   Kingsbury Commitment

   The Kingsbury Commitment settled a major antitrust threat. AT&T agreed to divest its Western Union holdings, connect independent telephone companies to its long-distance network and seek approval for further acquisitions.

4. 1925AT&T

   Bell Telephone Laboratories Founded

   AT&T and Western Electric consolidated their research into Bell Telephone Laboratories in 1925.

5. 1984AT&T

   Bell System Breakup Takes Effect

   Divestiture took effect on January 1, 1984 under the 1982 consent decree. AT&T gave up the local exchange operations that had produced most of its revenue, which became seven regional Bell operating companies, and kept long distance, Western Electric and Bell…

6. 1993AstraZeneca

   Zeneca Group Spun Off from ICI

   Imperial Chemical Industries demerges its pharmaceuticals and agrochemicals businesses to form Zeneca Group PLC, with initial products including Zestril, Nolvadex, and Zoladex generating approximately $3.2 billion in annual sales.

7. 1999AstraZeneca

   Astra and Zeneca Merge to Form AstraZeneca

   The all-share merger of equals completes on 6 April 1999, creating AstraZeneca PLC.

8. 2000AstraZeneca

   Nexium Launch Replaces Prilosec

   AstraZeneca launches Nexium (esomeprazole), the single-isomer successor to Losec/Prilosec, in Europe in 2000 and in the United States in 2001 after FDA approval on 20 February 2001.

9. 2005AT&T

   SBC Acquires AT&T Corporation and Takes the Name

   SBC Communications, one of the regional companies created by the 1984 breakup, acquired AT&T Corporation in 2005 for about $16 billion and adopted the AT&T name.

10. 2006AstraZeneca

    Acquisition of Cambridge Antibody Technology

    AstraZeneca agrees in May 2006 to buy Cambridge Antibody Technology for 1,320 pence a share, valuing the UK biotech at 702 million pounds or about $1.32 billion.

11. 2007AstraZeneca

    Acquisition of MedImmune for $15.6 Billion

    AstraZeneca acquires MedImmune for $15.6 billion, entering the biologics market and gaining the Synagis respiratory syncytial virus franchise and antibody technology platforms. The Gaithersburg facility becomes one of three global R&D centres.

12. 2007AT&T

    Exclusive US iPhone Launch Carrier

    AT&T, then operating wireless under the Cingular brand, was the exclusive U.S. carrier for Apple's first iPhone in 2007.

13. 2012AstraZeneca

    Pascal Soriot Appointed CEO

    Pascal Soriot joins AstraZeneca as Chief Executive Officer on October 1, 2012, with a base salary of $1.4 million and a mandate to reverse declining revenue and R&D productivity through science-led investment.

14. 2014AstraZeneca

    Pfizer Hostile Takeover Rejected

    AstraZeneca's board rejects a $117 billion hostile takeover offer from Pfizer, with Soriot arguing that the undervaluation would destroy long-term shareholder value and pipeline potential.

15. 2014AstraZeneca

    Acquisition of Almirall Respiratory Portfolio

    AstraZeneca acquires the respiratory portfolio of Spanish pharmaceutical company Almirall for approximately $2.1 billion, strengthening the company's position in COPD and asthma with products including Eklira and pipeline candidates that become Breztri.

16. 2015AstraZeneca

    Tagrisso Approved for EGFR-Mutated Lung Cancer

    The FDA approves Tagrisso (osimertinib) in November 2015 for metastatic EGFR T790M mutation-positive non-small cell lung cancer, the first product from Soriot's reinvestment strategy to reach market.

17. 2015AT&T

    DirecTV Acquisition Completed

    AT&T completed the DirecTV purchase on July 24, 2015 for $48.5 billion, about $67 billion including assumed debt, betting that satellite video would reinforce telecom relationships.

18. 2017AstraZeneca

    Imfinzi Approved Based on PACIFIC Trial

    The FDA approves Imfinzi (durvalumab) for unresectable stage III non-small cell lung cancer after chemoradiation, based on PACIFIC trial data showing survival benefits.

19. 2018AT&T

    Time Warner Acquisition Completed

    AT&T completed the $85.4 billion Time Warner purchase on June 14, 2018, two days after a federal judge rejected the Justice Department challenge. The deal brought HBO, Warner Bros.

20. 2020AstraZeneca

    COVID-19 Vaccine Development with Oxford University

    AstraZeneca partners with the University of Oxford to develop and manufacture the Vaxzevria COVID-19 vaccine, distributing billions of doses globally at nonprofit pricing during the pandemic peak.

21. 2020AT&T

    John T. Stankey Becomes CEO

    John T. Stankey became chief executive on July 1, 2020, inheriting high debt, a media portfolio under pressure and a shifting broadband market.

22. 2021AstraZeneca

    Acquisition of Alexion Pharmaceuticals for $39 Billion

    AstraZeneca completes the $39 billion acquisition of Alexion on July 21, 2021, entering the rare disease market with Soliris and Ultomiris and creating a dedicated rare disease unit headquartered in Boston.

23. 2022AT&T

    WarnerMedia Separated and Merged with Discovery

    AT&T separated WarnerMedia in April 2022 and combined it with Discovery to create Warner Bros. Discovery, receiving cash and debt relief of about $40.4 billion.

24. 2023AstraZeneca

    CinCor Pharma Acquired for up to $1.8 Billion

    AstraZeneca agrees on 9 January 2023 to acquire CinCor Pharma for up to $1.8 billion, $26 per share in cash plus a $10 per share contingent value right, to gain baxdrostat, an aldosterone synthase inhibitor for resistant hypertension.

25. 2023AT&T

    $14 Billion Open RAN Contract with Ericsson

    In December 2023 AT&T committed roughly $14 billion over five years to Ericsson to deploy commercial-scale open radio access network equipment, with a target of carrying 70% of its wireless traffic on open-capable platforms by late 2026.

26. 2024AstraZeneca

    Total Revenue Reaches $54.073 Billion

    AstraZeneca reports Total Revenue of $54.073 billion for fiscal year 2024, an 18% increase at actual rates and 21% at constant exchange rates, with 16 blockbuster medicines, 74 regulatory events, and 24 pipeline progression events.

27. 2024AstraZeneca

    Fusion Pharmaceuticals and Gracell Acquisitions

    AstraZeneca acquires Fusion Pharmaceuticals for $2 billion to access radiopharmaceutical technology and Gracell Biotechnologies for $1.2 billion for cell therapy manufacturing, expanding modality diversity into radiopharmaceuticals and CAR-T.

28. 2025AstraZeneca

    Total Revenue Reaches $58.739 Billion

    AstraZeneca reports Total Revenue of $58.739 billion for fiscal year 2025, an 8% increase at constant exchange rates, with 16 positive Phase III readouts, 43 major market approvals, and a commitment to invest $50 billion in U.S. manufacturing by 2030.

29. 2025AstraZeneca

    EsoBiotec Acquired for Up to $1 Billion

    AstraZeneca acquires Belgian biotech EsoBiotec for up to $1 billion to access in vivo cell therapy technology, eliminating the need for ex vivo manufacturing in CAR-T therapies.

30. 2025AstraZeneca

    $50 Billion US Manufacturing and R&D Commitment

    AstraZeneca announces on 21 July 2025 that it will invest $50 billion in United States manufacturing and research by 2030, including a new Virginia facility later raised to $4.5 billion.

31. 2025AT&T

    DIRECTV Exit Completed

    AT&T closed the sale of its entire remaining 70% DIRECTV stake to TPG on July 2, 2025, recording a $5.6 billion gain.

32. 2025AT&T

    Fiber Network Passes 30 Million Locations

    AT&T said in October 2025 that its fiber network had passed more than 30 million consumer and business locations, ahead of its own schedule, and finished the year at 32.0 million.

33. 2026AstraZeneca

    Ordinary Shares Begin Trading on the NYSE

    AstraZeneca ordinary shares start trading on the New York Stock Exchange on 2 February 2026 under the ticker AZN, after the American Depositary Share programme and certain debt securities stopped trading on Nasdaq on 30 January 2026.

34. 2026AstraZeneca

    Baxfendy Approved in the US for Hypertension

    The FDA approves Baxfendy (baxdrostat) in May 2026 as the first aldosterone synthase inhibitor for hypertension, used in combination with other antihypertensives in adults who are not adequately controlled.

35. 2026AstraZeneca

    $15 Billion China Investment Through 2030

    AstraZeneca announces on 29 January 2026 that it will invest $15 billion in China through 2030 to expand manufacturing and research, in a market that is its second largest and about 12% of revenue.

36. 2026AT&T

    Lumen Fiber and EchoStar Spectrum Deals Close

    AT&T completed two large network purchases in 2026. In February it closed the $5.75 billion acquisition of Lumen's mass markets fiber business, adding more than 1 million subscribers and more than 4 million fiber locations in eleven states.

Acquisitions

Questions about AstraZeneca vs AT&T